Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| ARL5A | RAB5B | RAB5B: Ras-related protein Rab-5B | 3.47 | Evidence | |||||
| ARL5A | CREBBP | CREBBP, CBP: CREB-binding protein | 2.28 | Evidence | |||||
| ARL5A | SFRS10 | SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 | 2.28 | Evidence | |||||
| ARL5A | NUP50 | NUP50, NPAP60L, PRO1146: Nucleoporin 50 kDa | 2.17 | Evidence | |||||
| ARL5A | RAB5A | RAB5A, RAB5: Ras-related protein Rab-5A | 0.522 | Evidence | |||||
| ARL5A | RELB | RELB: Transcription factor RelB | 0.185 | Evidence | |||||
| ARL5A | MNAR | PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 | 0.142 | Evidence | |||||
| ARL5A | APPL | APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha | 0.142 | Evidence | |||||
| ARL5A | NBN | NBN, NBS, NBS1, P95: Nibrin | 0.142 | Evidence | |||||
| ARL5A | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 0.142 | Evidence | |||||
| ARL5A | GRLF1 | N/A | 0.142 | Evidence | |||||
| ARL5A | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 0.142 | Evidence | |||||
| ARL5A | LNK | SH2B3, LNK: SH2B adapter protein 3 | 0.142 | Evidence | |||||
| ARL5A | WWC2 | WW and C2 domain containing 2 | 0.142 | Evidence | |||||
| ARL5A | IPO7 | IPO7: Uncharacterized protein IPO7 | 0.142 | Evidence | |||||
| ARL5A | ROCK1 | ROCK1: Rho-associated protein kinase 1 | 0.142 | Evidence | |||||
| ARL5A | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 0.142 | Evidence | |||||
| ARL5A | FRAP1 | FRAP1, FRAP, FRAP2: FKBP12-rapamycin complex-associated protein | 0.142 | Evidence | |||||
| ARL5A | NFIB | N/A | 0.142 | Evidence | |||||
| ARL5A | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 0.142 | Evidence | |||||
| ARL5A | GAB1 | GAB1: GRB2-associated-binding protein 1 | 0.142 | Evidence | |||||
| ARL5A | PKN1 | PKN1, PKN, PRK1, PRKCL1: Serine/threonine-protein kinase N1 | 0.142 | Evidence | |||||
| ARL5A | PSCD2 | N/A | 0.142 | Evidence | |||||
| ARL5A | DNM3 | DNM3: Uncharacterized protein DNM3 | 0.142 | Evidence | |||||
| ARL5A | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 0.142 | Evidence | |||||
| ARL5A | VASP | VASP: Vasodilator-stimulated phosphoprotein | 0.142 | Evidence | |||||
| ARL5A | ARHGEF12 | ARHGEF12, KIAA0382, LARG: Rho guanine nucleotide exchange factor 12 | 0.142 | Evidence | |||||
| ARL5A | IRF3 | IRF3: Interferon regulatory factor 3 | 0.142 | Evidence | |||||
| ARL5A | KIAA0528 | KIAA0528: Uncharacterized protein KIAA0528 | 0.142 | Evidence | |||||
| ARL5A | NF2 | NF2, SCH: Merlin | 0.142 | Evidence | |||||
| ARL5A | PRKDC | PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit | 0.142 | Evidence | |||||
| ARL5A | BMX | N/A | 0.142 | Evidence | |||||
| ARL5A | PSCD1 | PSCD1, D17S811E: Cytohesin-1 | 0.142 | Evidence | |||||
| ARL5A | PLEKHA5 | PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member | 0.142 | Evidence | |||||
| ARL5A | IRS2 | IRS2: Insulin receptor substrate 2 | 0.142 | Evidence | |||||
| ARL5A | PLEK | PLEK, P47: Pleckstrin | 0.142 | Evidence | |||||
| ARL5A | IRS1 | IRS1: Insulin receptor substrate 1 | 0.142 | Evidence | |||||
| ARL5A | PKP4 | PKP4: Plakophilin-4 | 0.142 | Evidence | |||||
| ARL5A | GAB2 | N/A | 0.142 | Evidence | |||||
| ARL5A | SPAG6 | SPAG6, PF16: Sperm-associated antigen 6 | 0.142 | Evidence | |||||
| ARL5A | HD | HD, IT15: Huntingtin | 0.142 | Evidence | |||||
| ARL5A | ARFGAP1 | N/A | 0.142 | Evidence | |||||
| ARL5A | PKP3 | PKP3: Plakophilin-3 | 0.142 | Evidence | |||||
| ARL5A | RASGRP2 | RASGRP2: RAS guanyl-releasing protein 2 | 0.128 | Evidence | |||||
| ARL5A | PLD2 | PLD2: Phospholipase D2 | 0.128 | Evidence | |||||
| ARL5A | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 0.128 | Evidence | |||||
| ARL5A | MYH9 | MYH9: Myosin-9 | 0.128 | Evidence | |||||
| ARL5A | DAB2 | DAB2, DOC2: Disabled homolog 2 | 0.128 | Evidence | |||||
| ARL5A | ARHGEF7 | N/A | 0.128 | Evidence | |||||
| ARL5A | DNMBP | DNMBP, KIAA1010: Dynamin-binding protein | 0.128 | Evidence | |||||
| ARL5A | DOK1 | DOK1: Docking protein 1 | 0.128 | Evidence | |||||
| ARL5A | MAPK8IP1 | MAPK8IP1, IB1, JIP1, PRKM8IP: C-jun-amino-terminal kinase-interacting protein 1 | 0.128 | Evidence | |||||
| ARL5A | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 0.128 | Evidence | |||||
| ARL5A | STAM2 | STAM2: Signal transducing adapter molecule 2 | 0.128 | Evidence | |||||
| ARL5A | MSN | MSN: Moesin | 0.128 | Evidence | |||||
| ARL5A | SNTA1 | SNTA1, SNT1: Alpha-1-syntrophin | 0.128 | Evidence | |||||
| ARL5A | SMAD1 | SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 | 0.128 | Evidence | O | ||||
| ARL5A | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 0.128 | Evidence | |||||
| ARL5A | RANBP2 | RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 | 0.128 | Evidence | |||||
| ARL5A | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 0.128 | Evidence | |||||
| ARL5A | EEA1 | EEA1, ZFYVE2: Early endosome antigen 1 | 0.128 | Evidence | |||||
| ARL5A | RAPGEF6 | RAPGEF6, PDZGEF2: Rap guanine nucleotide exchange factor 6 | 0.128 | Evidence | |||||
| ARL5A | FHOD1 | FHOD1, FHOS, FHOS1: FH1/FH2 domain-containing protein 1 | 0.128 | Evidence | |||||
| ARL5A | APBA2 | APBA2, MINT2, X11L: Amyloid beta A4 precursor protein-binding family A member 2 | 0.128 | Evidence | |||||
| ARL5A | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 0.128 | Evidence | |||||
| ARL5A | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 0.128 | Evidence | |||||
| ARL5A | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 0.128 | Evidence | |||||
| ARL5A | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 0.128 | Evidence | |||||
| ARL5A | GIT2 | N/A | 0.128 | Evidence | |||||
| ARL5A | CLASP1 | CLASP1, KIAA0622, MAST1: CLIP-associating protein 1 | 0.128 | Evidence | |||||
| ARL5A | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 0.128 | Evidence | |||||
| ARL5A | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 0.128 | Evidence | |||||
| ARL5A | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 0.128 | Evidence | |||||
| ARL5A | PSD | TYL: TYL protein | 0.128 | Evidence | |||||
| ARL5A | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 0.128 | Evidence | |||||
| ARL5A | TSC2 | TSC2, TSC4: Tuberin | 0.128 | Evidence | |||||
| ARL5A | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 0.128 | Evidence | |||||
| ARL5A | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 0.128 | Evidence | |||||
| ARL5A | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 0.128 | Evidence | |||||
| ARL5A | FER1L3 | FER1L3, KIAA1207, MYOF: Myoferlin | 0.128 | Evidence | |||||
| ARL5A | GIT1 | GIT1: ARF GTPase-activating protein GIT1 | 0.128 | Evidence | |||||
| ARL5A | XPO1 | XPO1, CRM1: Exportin-1 | 0.128 | Evidence | |||||
| ARL5A | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 0.128 | Evidence | |||||
| ARL5A | RASA3 | RASA3: Ras GTPase-activating protein 3 | 0.128 | Evidence | |||||
| ARL5A | RASGRP3 | RASGRP3, GRP3, KIAA0846: RAS guanyl-releasing protein 3 | 0.128 | Evidence | |||||
| ARL5A | PRKD2 | PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 | 0.128 | Evidence | |||||
| ARL5A | AKT3 | AKT3: RAC-gamma serine/threonine-protein kinase | 0.128 | Evidence | |||||
| ARL5A | IQSEC1 | IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein | 0.128 | Evidence | |||||
| ARL5A | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 0.128 | Evidence | |||||
| ARL5A | CTNNB1 | CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 | 0.128 | Evidence | |||||
| ARL5A | SF3B1 | SF3B1, SAP155: Splicing factor 3B subunit 1 | 0.128 | Evidence | |||||
| ARL5A | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 0.128 | Evidence | |||||
| ARL5A | SOS1 | SOS1: Son of sevenless homolog 1 | 0.128 | Evidence | |||||
| ARL5A | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 0.128 | Evidence | |||||
| ARL5A | ELMO1 | N/A | 0.128 | Evidence | |||||
| ARL5A | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 0.128 | Evidence | |||||
| ARL5A | BTAF1 | BTAF1, TAF172: TATA-binding protein-associated factor 172 | 0.128 | Evidence | |||||
| ARL5A | VIL2 | N/A | 0.128 | Evidence | |||||
| ARL5A | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 0.128 | Evidence | |||||
| ARL5A | FABP5 | FABP5: Fatty acid-binding protein, epidermal | 0.128 | Evidence | |||||
| ARL5A | ARHGAP12 | ARHGAP12: Rho GTPase-activating protein 12 | 0.128 | Evidence | |||||
| ARL5A | EPB41L1 | EPB41L1, KIAA0338: Band 4.1-like protein 1 | 0.128 | Evidence | |||||
| ARL5A | PIP5K3 | PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase | 0.128 | Evidence | |||||
| ARL5A | APS | SH2B2, APS: SH2B adapter protein 2 | 0.128 | Evidence | |||||
| ARL5A | FABP3 | FABP3, FABP11, MDGI: Fatty acid-binding protein, heart | 0.128 | Evidence | |||||
| ARL5A | SMAD4 | SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 | 0.128 | Evidence | O | ||||
| ARL5A | PKN2 | PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 | 0.128 | Evidence | |||||
| ARL5A | PSMD1 | PSMD1: 26S proteasome non-ATPase regulatory subunit 1 | 0.128 | Evidence | |||||
| ARL5A | CTNND2 | CTNND2, NPRAP: Catenin delta-2 | 0.128 | Evidence | |||||
| ARL5A | ITSN2 | ITSN2, KIAA1256, SH3D1B, SWAP: Intersectin-2 | 0.128 | Evidence | |||||
| ARL5A | DAB1 | DAB1: Disabled homolog 1 | 0.128 | Evidence | |||||
| ARL5A | OSBP | OSBP, OSBP1: Oxysterol-binding protein 1 | 0.128 | Evidence | |||||
| ARL5A | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 0.128 | Evidence | |||||
| ARL5A | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 0.128 | Evidence | |||||
| ARL5A | GMIP | GMIP: GEM-interacting protein | 0.128 | Evidence | |||||
| ARL5A | RDX | RDX: Radixin | 0.128 | Evidence | |||||
| ARL5A | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 0.128 | Evidence | |||||
| ARL5A | VAV1 | VAV1, VAV: Proto-oncogene vav | 0.128 | Evidence | |||||
| ARL5A | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 0.128 | Evidence | |||||
| ARL5A | PLCB3 | PLCB3: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 | 0.128 | Evidence | |||||
| ARL5A | ARHGEF6 | ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 | 0.128 | Evidence | |||||
| ARL5A | raptor | RAPTOR, KIAA1303: Regulatory-associated protein of mTOR | 0.128 | Evidence | |||||
| ARL5A | EPB41L3 | EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 | 0.128 | Evidence | |||||
| ARL5A | ARID1A | ARID1A, C1orf4, OSA1, SMARCF1: AT-rich interactive domain-containing protein 1A | 0.128 | Evidence | |||||
| ARL5A | SMAD3 | SMAD3, MADH3: Mothers against decapentaplegic homolog 3 | 0.128 | Evidence | |||||
| ARL5A | ATR | ATR, FRP1: Serine/threonine-protein kinase ATR | 0.128 | Evidence | |||||
| ARL5A | DGKD | DGKD, KIAA0145: Diacylglycerol kinase delta | 0.128 | Evidence | |||||
| ARL5A | ARVCF | ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome | 0.128 | Evidence | |||||
| ARL5A | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 0.128 | Evidence | |||||
| ARL5A | ARHGDIB | ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 | 0.128 | Evidence | |||||
| ARL5A | PLD1 | PLD1: Phospholipase D1 | 0.128 | Evidence | |||||
| ARL5A | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 0.128 | Evidence | |||||
| ARL5A | ANKS1A | ANKS1A, ANKS1, KIAA0229: Ankyrin repeat and SAM domain-containing protein 1A | 0.128 | Evidence | |||||
| ARL5A | PSCD4 | PSCD4, CYT4: Cytohesin-4 | 0.128 | Evidence | |||||
| ARL5A | ZFYVE16 | ZFYVE16, KIAA0305: Zinc finger FYVE domain-containing protein 16 | 0.128 | Evidence | |||||
| ARL5A | EPB41L2 | EPB41L2: Band 4.1-like protein 2 | 0.128 | Evidence | |||||
| ARL5A | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 0.128 | Evidence | |||||
| ARL5A | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 0.128 | Evidence | |||||
| ARL5A | CENTB2 | CENTB2, KIAA0041: Centaurin-beta 2 | 0.128 | Evidence | |||||
| ARL5A | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 0.128 | Evidence | |||||